Evaluation of the efficacy of transdermal administration of maropitant in managing vomiting in cats

BackgroundAntiemetic maropitant is a widely used medication for treating acute and chronic vomiting in cats. It is available as tablets or injectable solution (Cerenia®). With the oral and injectable routes being especially difficult to pursue in cats experiencing vomiting and nausea, the transderma...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Open veterinary journal 2022, Vol.12 (5), p.618-621
Hauptverfasser: Boukaache, Youcef, Ferret, Marie-Laurence, Khoukh, Valérie Delteil-Prévotat Karim, Enache, Andra, Iwaszkiw, Dorothée, Bertin, Sébastien, Bruno, Fabien
Format: Report
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 621
container_issue 5
container_start_page 618
container_title Open veterinary journal
container_volume 12
creator Boukaache, Youcef
Ferret, Marie-Laurence
Khoukh, Valérie Delteil-Prévotat Karim
Enache, Andra
Iwaszkiw, Dorothée
Bertin, Sébastien
Bruno, Fabien
description BackgroundAntiemetic maropitant is a widely used medication for treating acute and chronic vomiting in cats. It is available as tablets or injectable solution (Cerenia®). With the oral and injectable routes being especially difficult to pursue in cats experiencing vomiting and nausea, the transdermal administration might be an efficient alternative. The aim of this study was to demonstrate the antiemetic effect of maropitant administered via the transdermal route in cats. Case DescriptionThere were 8 cats enrolled in this study, weighing between 2 and 7 kg, more than 6 months old, and experiencing at least 2 episodes of vomiting in the last 72 hours. Compounded transdermal maropitant was prepared using finely ground Cerenia® tablets, dissolved in propylene glycol and incorporated in the commercial liposomal base Pentravan® (Fagron®, Thiais, France). The uniformity of content was determined using the high performance liquid chromatography (HPLC) method. The product was administered at a dosage of 4 mg/cat once a day (QD), applied on the inner pinna of the ear for five consecutive days. Monitoring and evaluation of vomiting frequency and nausea were performed. A significant decrease in vomiting frequency was observed in 6 of the 8 enrolled cats. A reduction in nausea, associated with an improvement of appetite, was observed in some cases. ConclusionTransdermal application of maropitant to cats experiencing vomiting seems to be efficient and a good alternative to existing oral medication, taking into account the difficulty of oral administration in these cases. This work provides preliminary clinical results of the efficacy of transdermal maropitant in cats. Further studies are necessary to determine dosing and pharmacokinetics.
doi_str_mv 10.5455/OVJ.2022.v12.i5.4
format Report
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_2760171582</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2760171582</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_27601715823</originalsourceid><addsrcrecordid>eNqVis1qAjEUhUNBqKgP0F2WbkyT68Sx66KUbrop3colZqZX8mPnZgZ8e6diH6Bnc873cYR4MlrZytrnj693BRpADQYUWVU9iCmA2a422upHsWA-6TG1WcOLmQq3GzD0WCgnmRtZvr30TUMO3eXGHSY--i5ikHiMlIhH9feO2OUzFUxFUhopYUuplUOOVH7HKB0WnotJg4H94t4zsdzvPl_fVucu__SeyyESOx8CJp97PkC90aY2dgvrf1yvtUFQgg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype><pqid>2760171582</pqid></control><display><type>report</type><title>Evaluation of the efficacy of transdermal administration of maropitant in managing vomiting in cats</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>African Journals Online (Open Access)</source><source>PubMed Central</source><creator>Boukaache, Youcef ; Ferret, Marie-Laurence ; Khoukh, Valérie Delteil-Prévotat Karim ; Enache, Andra ; Iwaszkiw, Dorothée ; Bertin, Sébastien ; Bruno, Fabien</creator><creatorcontrib>Boukaache, Youcef ; Ferret, Marie-Laurence ; Khoukh, Valérie Delteil-Prévotat Karim ; Enache, Andra ; Iwaszkiw, Dorothée ; Bertin, Sébastien ; Bruno, Fabien</creatorcontrib><description>BackgroundAntiemetic maropitant is a widely used medication for treating acute and chronic vomiting in cats. It is available as tablets or injectable solution (Cerenia®). With the oral and injectable routes being especially difficult to pursue in cats experiencing vomiting and nausea, the transdermal administration might be an efficient alternative. The aim of this study was to demonstrate the antiemetic effect of maropitant administered via the transdermal route in cats. Case DescriptionThere were 8 cats enrolled in this study, weighing between 2 and 7 kg, more than 6 months old, and experiencing at least 2 episodes of vomiting in the last 72 hours. Compounded transdermal maropitant was prepared using finely ground Cerenia® tablets, dissolved in propylene glycol and incorporated in the commercial liposomal base Pentravan® (Fagron®, Thiais, France). The uniformity of content was determined using the high performance liquid chromatography (HPLC) method. The product was administered at a dosage of 4 mg/cat once a day (QD), applied on the inner pinna of the ear for five consecutive days. Monitoring and evaluation of vomiting frequency and nausea were performed. A significant decrease in vomiting frequency was observed in 6 of the 8 enrolled cats. A reduction in nausea, associated with an improvement of appetite, was observed in some cases. ConclusionTransdermal application of maropitant to cats experiencing vomiting seems to be efficient and a good alternative to existing oral medication, taking into account the difficulty of oral administration in these cases. This work provides preliminary clinical results of the efficacy of transdermal maropitant in cats. Further studies are necessary to determine dosing and pharmacokinetics.</description><identifier>EISSN: 2218-6050</identifier><identifier>DOI: 10.5455/OVJ.2022.v12.i5.4</identifier><language>eng</language><ispartof>Open veterinary journal, 2022, Vol.12 (5), p.618-621</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>780,784,864,4488,27923</link.rule.ids></links><search><creatorcontrib>Boukaache, Youcef</creatorcontrib><creatorcontrib>Ferret, Marie-Laurence</creatorcontrib><creatorcontrib>Khoukh, Valérie Delteil-Prévotat Karim</creatorcontrib><creatorcontrib>Enache, Andra</creatorcontrib><creatorcontrib>Iwaszkiw, Dorothée</creatorcontrib><creatorcontrib>Bertin, Sébastien</creatorcontrib><creatorcontrib>Bruno, Fabien</creatorcontrib><title>Evaluation of the efficacy of transdermal administration of maropitant in managing vomiting in cats</title><title>Open veterinary journal</title><description>BackgroundAntiemetic maropitant is a widely used medication for treating acute and chronic vomiting in cats. It is available as tablets or injectable solution (Cerenia®). With the oral and injectable routes being especially difficult to pursue in cats experiencing vomiting and nausea, the transdermal administration might be an efficient alternative. The aim of this study was to demonstrate the antiemetic effect of maropitant administered via the transdermal route in cats. Case DescriptionThere were 8 cats enrolled in this study, weighing between 2 and 7 kg, more than 6 months old, and experiencing at least 2 episodes of vomiting in the last 72 hours. Compounded transdermal maropitant was prepared using finely ground Cerenia® tablets, dissolved in propylene glycol and incorporated in the commercial liposomal base Pentravan® (Fagron®, Thiais, France). The uniformity of content was determined using the high performance liquid chromatography (HPLC) method. The product was administered at a dosage of 4 mg/cat once a day (QD), applied on the inner pinna of the ear for five consecutive days. Monitoring and evaluation of vomiting frequency and nausea were performed. A significant decrease in vomiting frequency was observed in 6 of the 8 enrolled cats. A reduction in nausea, associated with an improvement of appetite, was observed in some cases. ConclusionTransdermal application of maropitant to cats experiencing vomiting seems to be efficient and a good alternative to existing oral medication, taking into account the difficulty of oral administration in these cases. This work provides preliminary clinical results of the efficacy of transdermal maropitant in cats. Further studies are necessary to determine dosing and pharmacokinetics.</description><issn>2218-6050</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2022</creationdate><recordtype>report</recordtype><recordid>eNqVis1qAjEUhUNBqKgP0F2WbkyT68Sx66KUbrop3colZqZX8mPnZgZ8e6diH6Bnc873cYR4MlrZytrnj693BRpADQYUWVU9iCmA2a422upHsWA-6TG1WcOLmQq3GzD0WCgnmRtZvr30TUMO3eXGHSY--i5ikHiMlIhH9feO2OUzFUxFUhopYUuplUOOVH7HKB0WnotJg4H94t4zsdzvPl_fVucu__SeyyESOx8CJp97PkC90aY2dgvrf1yvtUFQgg</recordid><startdate>20220901</startdate><enddate>20220901</enddate><creator>Boukaache, Youcef</creator><creator>Ferret, Marie-Laurence</creator><creator>Khoukh, Valérie Delteil-Prévotat Karim</creator><creator>Enache, Andra</creator><creator>Iwaszkiw, Dorothée</creator><creator>Bertin, Sébastien</creator><creator>Bruno, Fabien</creator><scope>7X8</scope></search><sort><creationdate>20220901</creationdate><title>Evaluation of the efficacy of transdermal administration of maropitant in managing vomiting in cats</title><author>Boukaache, Youcef ; Ferret, Marie-Laurence ; Khoukh, Valérie Delteil-Prévotat Karim ; Enache, Andra ; Iwaszkiw, Dorothée ; Bertin, Sébastien ; Bruno, Fabien</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_27601715823</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Boukaache, Youcef</creatorcontrib><creatorcontrib>Ferret, Marie-Laurence</creatorcontrib><creatorcontrib>Khoukh, Valérie Delteil-Prévotat Karim</creatorcontrib><creatorcontrib>Enache, Andra</creatorcontrib><creatorcontrib>Iwaszkiw, Dorothée</creatorcontrib><creatorcontrib>Bertin, Sébastien</creatorcontrib><creatorcontrib>Bruno, Fabien</creatorcontrib><collection>MEDLINE - Academic</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boukaache, Youcef</au><au>Ferret, Marie-Laurence</au><au>Khoukh, Valérie Delteil-Prévotat Karim</au><au>Enache, Andra</au><au>Iwaszkiw, Dorothée</au><au>Bertin, Sébastien</au><au>Bruno, Fabien</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>Evaluation of the efficacy of transdermal administration of maropitant in managing vomiting in cats</atitle><jtitle>Open veterinary journal</jtitle><date>2022-09-01</date><risdate>2022</risdate><volume>12</volume><issue>5</issue><spage>618</spage><epage>621</epage><pages>618-621</pages><eissn>2218-6050</eissn><abstract>BackgroundAntiemetic maropitant is a widely used medication for treating acute and chronic vomiting in cats. It is available as tablets or injectable solution (Cerenia®). With the oral and injectable routes being especially difficult to pursue in cats experiencing vomiting and nausea, the transdermal administration might be an efficient alternative. The aim of this study was to demonstrate the antiemetic effect of maropitant administered via the transdermal route in cats. Case DescriptionThere were 8 cats enrolled in this study, weighing between 2 and 7 kg, more than 6 months old, and experiencing at least 2 episodes of vomiting in the last 72 hours. Compounded transdermal maropitant was prepared using finely ground Cerenia® tablets, dissolved in propylene glycol and incorporated in the commercial liposomal base Pentravan® (Fagron®, Thiais, France). The uniformity of content was determined using the high performance liquid chromatography (HPLC) method. The product was administered at a dosage of 4 mg/cat once a day (QD), applied on the inner pinna of the ear for five consecutive days. Monitoring and evaluation of vomiting frequency and nausea were performed. A significant decrease in vomiting frequency was observed in 6 of the 8 enrolled cats. A reduction in nausea, associated with an improvement of appetite, was observed in some cases. ConclusionTransdermal application of maropitant to cats experiencing vomiting seems to be efficient and a good alternative to existing oral medication, taking into account the difficulty of oral administration in these cases. This work provides preliminary clinical results of the efficacy of transdermal maropitant in cats. Further studies are necessary to determine dosing and pharmacokinetics.</abstract><doi>10.5455/OVJ.2022.v12.i5.4</doi></addata></record>
fulltext fulltext
identifier EISSN: 2218-6050
ispartof Open veterinary journal, 2022, Vol.12 (5), p.618-621
issn 2218-6050
language eng
recordid cdi_proquest_miscellaneous_2760171582
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; African Journals Online (Open Access); PubMed Central
title Evaluation of the efficacy of transdermal administration of maropitant in managing vomiting in cats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T00%3A25%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=Evaluation%20of%20the%20efficacy%20of%20transdermal%20administration%20of%20maropitant%20in%20managing%20vomiting%20in%20cats&rft.jtitle=Open%20veterinary%20journal&rft.au=Boukaache,%20Youcef&rft.date=2022-09-01&rft.volume=12&rft.issue=5&rft.spage=618&rft.epage=621&rft.pages=618-621&rft.eissn=2218-6050&rft_id=info:doi/10.5455/OVJ.2022.v12.i5.4&rft_dat=%3Cproquest%3E2760171582%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2760171582&rft_id=info:pmid/&rfr_iscdi=true